Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Synergy CHC Has UrgentRx Ticket To Enter OTC Market

This article was originally published in The Tan Sheet

Executive Summary

Synergy also acquires Australian brand Flat Tummy Tea. Both deals partly are financed through a $5.5m loan from Knight Therapeutics, a Canadian firm that in January also provided Synergy with a $6m loan to acquire the Focusfactor dietary supplement brand.

You may also be interested in...



Interview: Fugate Attracted By UrgentRx Focus On Branding, Unique Positioning

Ron Fugate sees UrgentRx not only using some of the strongest marketing strategies he’s known for building a successful consumer health care product brand, but also making headway in new areas important to driving sales for new products.

Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign

Campaign featuring actress Meghann Fahy says "allergy sufferers can relieve their allergy symptoms and be more spontaneous in their romantic pursuits.” Ads launch two months after FDA granted tentative approval for two ANDAs for generic equivalents, indicating approval could come pending resolution of patent litigation.

US Infant Formula Supply Chain Strategy Delivered

FDA immediate actions include ensuring providers know they’re required to develop redundancy risk management plans, enhancing inspections of manufacturers, including by expanding and improving training for investigators, and expediting reviews of premarket submissions for new products.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS108035

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel